North America Embolization Coils Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Detachable Coil and Pushable Coil), By Material (Platinum, Platinum & Hydrogel, and Platinum Tungsten Alloy), By Application (Neurology, Cardiology

North America Embolization Coils Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Detachable Coil and Pushable Coil), By Material (Platinum, Platinum & Hydrogel, and Platinum Tungsten Alloy), By Application (Neurology, Cardiology, Urology, Oncology, Peripheral Vascular Disease, and Others), and End User (Hospital, Cardiac Center, Ambulatory Center, and Other)

The North America embolization coils market is expected to grow from US$ 506.49 million in 2022 to US$ 661.63 million by 2028; it is estimated to grow at a CAGR of 4.6% from 2022 to 2028.

Increase in Incidence of Cancer Cases is Boosting the North America Embolization Coils Market

The five most common types of cancer are breast, prostate, cervical, lung, and colorectal. However, of these five cancers, the leading cause of cancer-related death is lung cancer. Even though breast cancer has at least a 25% higher incidence among women, cervical carcinoma was the leading cause of death in 2020. This significant cancer burden is predicted to increase in the coming decades, with the incidence of new cases of cancer expected to rise to 138,000 and 175,000 by 2030 and 2040, respectively. Cancer-related mortality is predicted to rise to 73,000 and 94,000 during the same period. Moreover, according to the American Cancer Society journal, in 2021, an estimated 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths in the United States. Embolization is used to stop bleeding or block blood flow to a tumor or abnormal area of tissue. It is also used to treat liver and kidney cancer and neuroendocrine tumors. Embolizing coils include detachable coils and pushable coils, which are used to fill or close blood vessels. The pushable coils are mechanical embolic agents used both in arteries and veins for various indications such as controlling bleeding, occluding vascular lesions such as aneurysms, varices, and arteriovenous fistulas, and redistributing blood flow to protect non-target vessels. The vascular embolization device (previously the arterial embolization device) is intended to control hemorrhaging due to aneurysms, certain types of tumors, and arteriovenous malformations. The pipeline embolization device is used to treat large and giant wide-neck intracranial aneurysms in the internal carotid artery. It helps prevent aneurysms and tumors from growing and causing harm to essential organs. Thus, the rising prevalence of cancer cases is creating a high demand for embolization coils. This is bolstering the growth of the North America embolization coils market .

North America Embolization Coils Market Overview

North America region includes countries such as the US, Canada, and Mexico. All the three countries in the region are witnessing a sequential change in the embolization coils market. North America has the largest market share of the embolization coils market, by region. The market in the region is expected to grow significantly due to the rise in the number of FDA approvals to companies manufacturing embolization coils. In the US, the embolization coils market is anticipated to grow significantly owing to the rising number of brain aneurysms.

North America embolization coils Market Revenue and Forecast to 2028 (US$ Million)

North America embolization coils market Segmentation

The North America embolization coils market is segmented on the basis of type, material, application, end user, and country. Based on type, the North America embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2022.

Based on material, the North America embolization coils market is segmented into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2022.

Based on application, the North America embolization coils market is segmented into neurology, cardiology, urology, oncology, peripheral vascular disease, and others. The neurology segment held the largest market share in 2022.

Based on end user, the North America embolization coils market is segmented into hospital, cardiac center, ambulatory center, and other. The hospital segment held the largest market share in 2022.

Based on country, the North America embolization coils market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.

Terumo Corporation; Medtronic; Boston Scientific Corporation; Stryker; KANEKA CORPORATION; MicroPort Scientific Corporation; Penumbra, Inc.; Cook Medical LLC; Johnson & Johnson Services, Inc.; and Shape Memory Medical INC. are the leading companies operating in the North America embolization coils market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America embolization coils market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America embolization coils market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America embolization coils market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution